The wellness platform's results arrived amid heightened legal and regulatory scrutiny over its weight-loss-drug business Hims & Hers reported quarterly results Monday after the closing bell. Shares of ...

Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...

All pharma brands airing during the Super Bowl got a boost over the broader pharma category, per Verve for Advertisers. Novartis scored the highest among any pharma or health brand on USA Today’s Ad ...

As the Super Bowl approached halftime, Hims & Hers publicly staked its claim to preventive medicine in front of the American people. In a one-minute ad, the direct-to-consumer health company ...

Shares of Hims & Hers fell after hours on Monday after the wellness platform’s first-quarter profit forecast missed expectations, pressured by the money it spent on a Super Bowl ad and planned ...